Salesforce.com to B...
Health Care: Health Services
CAS Medical Systems Inc. (CASM: NASDAQ)
$1.92 0.00 | 0.00%
06/04/12 - 09:30 AM ET
Company Income Statement
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Sales | 22.45M | 24.09M | 34.24M | 40.65M |
| Cost of Sales | 13.00M | 13.30M | 22.30M | 25.71M |
| Gross Operating Profit | 9.45M | 10.78M | 11.94M | 14.94M |
| Selling, General, and Administrative Expenses | 11.51M | 9.96M | 11.60M | 12.16M |
| Research & Development | 3.53M | 1.69M | 2.46M | 2.03M |
| Operating Income before D & A (EBITDA) | -5.59M | -862.18K | -2.12M | 742.00K |
| Depreciation & Amortization | 888.26K | 825.81K | 1.05M | 1.03M |
| Interest Income | 0.00 | 0.00 | 0.00 | 272.00K |
| Other Income - Net | 53.48K | 0.00 | -2.16M | -545.00K |
| Special Income / Charges | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income Before Interest Expenses (EBIT) | -6.42M | -1.69M | -5.33M | -565.00K |
| Interest Expense | 26.74K | 59.93K | 224.22K | 0.00 |
| Pre-Tax Income | -6.45M | -1.75M | -5.56M | -565.00K |
| Income Taxes | -124.76K | -147.92K | 231.81K | -176.00K |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | -6.33M | -1.60M | -5.79M | -388.00K |
| Net Income From Discontinued Operations | 242.19K | 294.92K | 0.00 | 0.00 |
| Net Income From Total Operations | -6.08M | -1.31M | -5.79M | -388.00K |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | -6.08M | -1.31M | -5.79M | -388.00K |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-6.33M | -1.60M | -5.79M | -388.00K |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | -6.96M | -1.60M | -5.79M | -388.00K |
| Basic EPS from Continuing Ops. | -0.53 | -0.13 | -0.51 | -0.04 |
| Basic EPS from Discontinued Ops. | 0.02 | 0.02 | 0.00 | 0.00 |
| Basic EPS from Total Operations | -0.51 | -0.11 | -0.51 | -0.04 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | -0.51 | -0.11 | -0.51 | -0.04 |
| Basic Normalized Net Income/Share | -0.53 | -0.13 | -0.51 | -0.04 |
| EPS fr Continuing Ops. | -0.53 | -0.13 | -0.51 | -0.04 |
| EPS fr Discontinued Ops | 0.02 | 0.02 | 0.00 | 0.00 |
| EPS fr Total Ops. | -0.51 | -0.11 | -0.51 | -0.04 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | -0.51 | -0.11 | -0.51 | -0.04 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-0.53 | -0.13 | -0.51 | -0.04 |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with CASM
- Portfolio NameUser Type
- UserAshley
- ContributorUnder-$10 Setting Up To Tra...
- Contributor26 Small-Cap Stocks in Dang...
- Contributor8 Health Care Penny Stocks ...
- Usermsi Portfolio 1
- UserJane's SEP
- Userleon16066 Portfolio 1
- UserAdam Portfolio 1
Latest CASM Headlines from TheStreet
- 5 Stocks Under $10 Poised to Move Higher 04.05.12 | 01:04 pm
- CASMED Reports Fourth Quarter And Full Year 2010 Results 03.02.11 | 08:03 am
- CASMED Announces Fourth Quarter And Year-End 2010 Earnings Release Date And Conference Call Information 02.23.11 | 08:02 am
- CASMED Receives FDA Clearance For Non-Cerebral Indication Of FORE-SIGHT Absolute Tissue Oximeter 01.18.11 | 08:01 am
- CASMED Reports Inducement Grants To VP Of Sales And Marketing Matthew J. Herwig Under NASDAQ Marketplace Rule 5635 01.10.11 | 10:01 am
- CASMED Announces Key Addition To Executive Management Team 01.10.11 | 08:01 am
- CASMED Reports Third Quarter 2010 Results 11.10.10 | 04:11 pm
- CASMED Announces Third Quarter 2010 Earnings Release Date And Conference Call Information 11.03.10 | 08:11 am
- Gregory Rainey Appointed To CASMED Board 11.01.10 | 03:11 pm
- CASMED Announces 9 Scientific Abstracts Demonstrating The Benefits Of FORE-SIGHT Absolute Oximetry 10.21.10 | 08:10 am
Press Releases for CASM
Partner Headlines for CASM
- CASMED Reports Third Quarter EPS of $(0.04) - Benzinga 11.10.10 | 04:11 pm
- UPDATE 1-CAS Medical gets new Japanese patent, shares jump - Reuters 04.13.10 | 10:04 am
